Skip to main content
Clinical Trials/NCT06306898
NCT06306898CompletedNot Applicable

Intra-Arrest-Ventilation - a Prospective Randomized Trial in Human Cadavers

Gerrit Jansen2 sites in 1 country10 target enrollmentStarted: March 18, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
10
Locations
2
Primary Endpoint
Ventilation Pressure with different Airway devices in CCSV

Study Overview

Brief Summary

The study investigates the influence of non-synchronized bag-device-ventilation and intermittent positive pressure ventilation (IPPV), as recommended in the current resuscitation guidelines of the European Resuscitation Concil (tidal Volume (Vt) = 5-6 mL/kg body weight, respiratory rate = 10 min-1) and Chest Compression Synchronized Ventilation (pInsp = 40 mbar; respiratory rate = chest compression rate) with regard to achieving a sufficient tidal volume and the tightness of various supraglottic airway devices (laryngeal mask, i-Gel-laryngeal mask, laryngeal tube) and endotracheal intubation.

Detailed Description

The European Resuscitation Council (ERC) guidelines for cardiopulmonary resuscitation (CPR) recommend uninterrupted chest compressions and continuous ventilation as soon as a patient is endotracheally intubated or a supraglottic airway (SGA) is positioned.

Recently, SGAs have been adopted by emergency medical services worldwide as the primary tool for airway management during CPR. SGAs offer limited protection against aspiration compared to endotracheal intubation (ETI) and may increase the risk of aspiration. A new ventilation mode (Chest Compression Synchronized Ventilation [CCSV]) is now available for resuscitation with uninterrupted chest compressions.

The study investigates the influence of non-synchronized bag-device-ventilation, intermittent positive pressure ventilation (IPPV), as recommended in the current resuscitation guidelines of the ERC (Vt = 5-6 mL/kg bw, AF = 10 min-1) and CCSV (pInsp = 40 mbar; RR = chest compression rate) with regard to achieving a sufficient tidal volume and the tightness of various SGA (laryngeal mask, iGel, laryngeal tube) and endotracheal intubation.

Gender, age, height and weight are documented (external post-mortem examination). The respective body donor is randomly assigned to a group. The grouping determines the order in which the means of airway management (SGA, ETI) are used.

Initial airway management is performed with an ETI with blockage of 30 mmH2O). The body donor is then bronchoscoped. A gastric tube is placed and the pressure probe to be used is calibrated if necessary. Positive pressure ventilation (pInsp = 40 mbar, positive end-expiratory pressure (PEEP) = 12 mbar, frequency = 10 min-1) is performed for 2 minutes to recruit the lungs. Vt is documented.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 100 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • > 17 Years of Age

Exclusion Criteria

  • Adult respiratory distress syndrome (ARDS)
  • Severe lung or thoracic injuries
  • pneumothorax
  • Abnormal airways
  • Tracheostoma
  • severe aspirations

Arms & Interventions

Bag-Device-Ventilation

Active Comparator

Ventilation with a Ventilation Bag

Intervention: Laryngeal mask (Other)

Bag-Device-Ventilation

Active Comparator

Ventilation with a Ventilation Bag

Intervention: I-Gel-Laryngeal Mask (Other)

IPPV

Active Comparator

Intermittend-Positive-Pressure-Ventilation

Intervention: Endotracheal Intubation (Other)

IPPV

Active Comparator

Intermittend-Positive-Pressure-Ventilation

Intervention: Laryngeal tube (Other)

IPPV

Active Comparator

Intermittend-Positive-Pressure-Ventilation

Intervention: Laryngeal mask (Other)

IPPV

Active Comparator

Intermittend-Positive-Pressure-Ventilation

Intervention: I-Gel-Laryngeal Mask (Other)

CCSV

Active Comparator

Chest Compression Synchronized Ventilation

Intervention: Endotracheal Intubation (Other)

CCSV

Active Comparator

Chest Compression Synchronized Ventilation

Intervention: Laryngeal tube (Other)

CCSV

Active Comparator

Chest Compression Synchronized Ventilation

Intervention: Laryngeal mask (Other)

CCSV

Active Comparator

Chest Compression Synchronized Ventilation

Intervention: I-Gel-Laryngeal Mask (Other)

Bag-Device-Ventilation

Active Comparator

Ventilation with a Ventilation Bag

Intervention: Endotracheal Intubation (Other)

Bag-Device-Ventilation

Active Comparator

Ventilation with a Ventilation Bag

Intervention: Laryngeal tube (Other)

Outcomes

Primary Outcomes

Ventilation Pressure with different Airway devices in CCSV

Time Frame: After beginning of ventilation up to 4 minutes each device

Expiratory Volume with different Airway Devices in IPPV

Time Frame: After beginning of ventilation up to 4 minutes each device

Mean expiratory Volume with different Airway Devices in IPPV

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Gerrit Jansen

Principal Investigator

Muehlenkreiskliniken, MKK

Study Sites (2)

Loading locations...

Similar Trials